Xponance, Inc.
- SEC CIK
- 0001637541
- Latest filing
- Aug 10, 2026
LYEL holding history
Lyell Immunopharma, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LYEL overviewAll 13F holders of LYELFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −563−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q1 2025 | 11,269 | $6.06K | <0.1% | +271+2.5% | Added | Holders |
| Q4 2024 | 10,998 | $7.04K | <0.1% | +948+9.4% | Added | Holders |
| Q3 2024 | 10,050 | $13.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 10,050 | $14.6K | <0.1% | −620−5.8% | Reduced | Holders |
| Q1 2024 | 10,670 | $23.8K | <0.1% | +390+3.8% | Added | Holders |
| Q4 2023 | 10,280 | $19.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,280 | $15.1K | <0.1% | +10,280 | New | Holders |